Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Cervical Cancer, July 2017

Free Subscription


Abstracts

Retrieve all available abstracts of the following 193 articles:
HTML format


 

Single Articles

  1. MATSUO K, Machida H, Horowitz MP, Shahzad MMK, et al
    Risk of metachronous ovarian cancer after ovarian conservation in young women with stage I cervical cancer.
    Am J Obstet Gynecol. 2017 Jun 27. pii: S0002-9378(17)30788.
    Abstract    

    Abstract available

  2. MCDOWELL M, Pardee DJ, Peitzmeier S, Reisner SL, et al
    Cervical Cancer Screening Preferences Among Trans-Masculine Individuals: Patient-Collected Human Papillomavirus Vaginal Swabs Versus Provider-Administered Pap Tests.
    LGBT Health. 2017 Jun 30. doi: 10.1089/lgbt.2016.0187.
    Abstract    

    Abstract available

  3. SABIK LM, Tarazi WW, Hochhalter S, Dahman B, et al
    Medicaid Expansions and Cervical Cancer Screening for Low-Income Women.
    Health Serv Res. 2017 Jun 30. doi: 10.1111/1475-6773.12732.
    Abstract    

    Abstract available

  4. ZIGRAS T, Lennox G, Willows K, Covens A, et al
    Early Cervical Cancer: Current Dilemmas of Staging and Surgery.
    Curr Oncol Rep. 2017;19:51.
    Abstract    

    Abstract available

  5. HASS P, Eggemann H, Costa SD, Ignatov A, et al
    Adjuvant hysterectomy after radiochemotherapy for locally advanced cervical cancer.
    Strahlenther Onkol. 2017 Jun 28. doi: 10.1007/s00066-017-1174.
    Abstract    

    Abstract available

  6. DUARTE DV, Vieira RC, Brito EB, Pinheiro MDCN, et al
    Prevalence of Human Papillomavirus Infection and Cervical Cancer Screening among Riverside Women of the Brazilian Amazon.
    Rev Bras Ginecol Obstet. 2017 Jun 28. doi: 10.1055/s-0037-1604027.
    Abstract    

    Abstract available

  7. LIM S, Lee KB
    Use of a cognitive computing system for treatment of cervical cancer.
    J Gynecol Oncol. 2017.
    Abstract    



  8. DONG L, Feng RM, Zhang L, Xu XQ, et al
    Prospective comparison of hybrid capture 2 and SPF(1)(0)-LiPA for carcinogenic human papillomavirus detection and risk prediction of cervical cancer: a population-based cohort study in China.
    J Gynecol Oncol. 2017.
    Abstract    

    Abstract available

  9. SHIM SH, Kim H, Sohn IS, Hwang HS, et al
    Nationwide cervical cancer screening in Korea: data from the National Health Insurance Service Cancer Screening Program and National Cancer Screening Program, 2009-2014.
    J Gynecol Oncol. 2017.
    Abstract    

    Abstract available

  10. LORA D, Gomez de la Camara A, Fernandez SP, Enriquez de Salamanca R, et al
    Prognostic models for locally advanced cervical cancer: external validation of the published models.
    J Gynecol Oncol. 2017.
    Abstract    

    Abstract available

  11. BO H, Weiyang C, Zhang Y
    p53R2 is oncogenic in human cervical cancer.
    Cell Cycle. 2017 Jun 28:1-2. doi: 10.1080/15384101.2017.1337978.
    Abstract    



  12. AKBAS T, Ugurluer G, Acil M, Arpaci T, et al
    Intraoperative sonographic guidance for intracavitary brachytherapy of cervical cancer.
    J Clin Ultrasound. 2017 Jun 27. doi: 10.1002/jcu.22510.
    Abstract    

    Abstract available

  13. LI B, Li X, Xiong H, Zhou P, et al
    Inhibition of COX2 enhances the chemosensitivity of dichloroacetate in cervical cancer cells.
    Oncotarget. 2017 Jun 16. doi: 10.18632/oncotarget.18518.
    Abstract    

    Abstract available

  14. SU PH, Hsu YW, Huang RL, Weng YC, et al
    Methylomics of nitroxidative stress on precancerous cells reveals DNA methylation alteration at the transition from in situ to invasive cervical cancer.
    Oncotarget. 2017 Jun 6. doi: 10.18632/oncotarget.18370.
    Abstract    

    Abstract available

  15. JIANG N, Xie F, Guo Q, Li MQ, et al
    Toll-like receptor 4 promotes proliferation and apoptosis resistance in human papillomavirus-related cervical cancer cells through the Toll-like receptor 4/nuclear factor-kappaB pathway.
    Tumour Biol. 2017;39:1010428317710586.
    Abstract    

    Abstract available

  16. KIRO NE, Hamblin MR, Abrahamse H
    Photobiomodulation of breast and cervical cancer stem cells using low-intensity laser irradiation.
    Tumour Biol. 2017;39:1010428317706913.
    Abstract    

    Abstract available

  17. YANG M, Zhai X, Ge T, Yang C, et al
    MiR-181a-5p Promotes Proliferation and Invasion, and Inhibits Apoptosis of Cervical Cancer Cells via Regulating Inositol Polyphosphate-5-Phosphatase A (INPP5A).
    Oncol Res. 2017 Jun 23. doi: 10.3727/096504017X14982569377511.
    Abstract    

    Abstract available

  18. PIYATHILAKE CJ, Badiga S, Borak SG, Weragoda J, et al
    A higher degree of expression of DNA methyl transferase 1 in cervical cancer is associated with poor survival outcome.
    Int J Womens Health. 2017;9:413-420.
    Abstract    

    Abstract available


  19. Disruption of human papillomavirus 16 E6 gene by clustered regularly interspaced short palindromic repeat/Cas system in human cervical cancer cells [Retraction].
    Onco Targets Ther. 2017;10:2835.
    Abstract    

    Abstract available

  20. PANG H, Yue X
    MiR-205 serves as a prognostic factor and suppresses proliferation and invasion by targeting insulin-like growth factor receptor 1 in human cervical cancer.
    Tumour Biol. 2017;39:1010428317701308.
    Abstract    

    Abstract available

  21. MELAN K, Janky E, Macni J, Ulric-Gervaise S, et al
    Epidemiology and survival of cervical cancer in the French West-Indies: data from the Martinique Cancer Registry (2002-2011).
    Glob Health Action. 2017;10:1337341.
    Abstract    

    Abstract available

  22. CUROTTO M, Barletta P, Paolino M, Arrossi S, et al
    [Health agents' perspective on the incorporation of self-collected samples in HPV screening programs].
    Cad Saude Publica. 2017;33:e00138515.
    Abstract    

    Abstract available

  23. LIMA PC, Teixeira J, Aires GN, Andrade LA, et al
    Endocervical gastric-type adenocarcinoma, an unrelated HPV tumour: difficulties in screening and diagnosis.
    BMJ Case Rep. 2017;2017.
    Abstract    

    Abstract available

  24. FENG Z, Tao C, Zhu J, Chen J, et al
    An integrated strategy of biological and physical constraints in biological optimization for cervical carcinoma.
    Radiat Oncol. 2017;12:64.
    Abstract    

    Abstract available

  25. XU JZ, Wen F, Wang XR
    The eIF3a Arg803Lys genetic polymorphism is associated with susceptibility to and chemoradiotherapy efficacy in cervical carcinoma.
    Kaohsiung J Med Sci. 2017;33:187-194.
    Abstract    

    Abstract available

  26. NI J, Yin ZM, Yuan SH, Liu NF, et al
    [A randomized study of intensity-modulated radiation therapy versus three dimensional conformal radiation therapy for pelvic radiation in patients of post-operative treatment with gynecologic malignant tumor].
    Zhonghua Fu Chan Ke Za Zhi. 2017;52:168-174.
    Abstract    

    Abstract available

  27. BODE-LESNIEWSKA B, Caduff R

    Praxis (Bern 1994). 2017;106:305-310.
    Abstract    



  28. SABEENA S, Bhat P, Kamath V, Arunkumar G, et al
    Possible non-sexual modes of transmission of human papilloma virus.
    J Obstet Gynaecol Res. 2017;43:429-435.
    Abstract    

    Abstract available

  29. FAN SL, Ding L, Ren ZY, Chen X, et al
    [Effect of extracellular signal-regulated kinas 1/2 expression and HPV16 infection and their interaction in progression of cervical cancerization].
    Zhonghua Liu Xing Bing Xue Za Zhi. 2017;38:96-101.
    Abstract    

    Abstract available

  30. WADSTROM H, Arkema EV, Sjowall C, Askling J, et al
    Cervical neoplasia in systemic lupus erythematosus: a nationwide study.
    Rheumatology (Oxford). 2017;56:613-619.
    Abstract    

    Abstract available

  31. YANG Y, Yu L, Li J, Yuan YH, et al
    Autophagy regulates the stemness of cervical cancer stem cells.
    Biologics. 2017;11:71-79.
    Abstract    

    Abstract available

  32. TYAGI A, Vishnoi K, Kaur H, Srivastava Y, et al
    Cervical cancer stem cells manifest radioresistance: Association with upregulated AP-1 activity.
    Sci Rep. 2017;7:4781.
    Abstract    

    Abstract available

  33. LIANG D, Xu W, Zhang Q, Tao BB, et al
    Study on the effect of Integrin alphaVbeta6 on proliferation and apoptosis of cervical cancer cells.
    Eur Rev Med Pharmacol Sci. 2017;21:2811-2815.
    Abstract    

    Abstract available

  34. ZHANG H, Yan T, Liu Z, Wang J, et al
    MicroRNA-137 is negatively associated with clinical outcome and regulates tumor development through EZH2 in cervical cancer.
    J Cell Biochem. 2017 Jul 6. doi: 10.1002/jcb.26259.
    Abstract    

    Abstract available

  35. ALI A, Kim SH, Kim MJ, Choi MY, et al
    O-GlcNAcylation of NF-kappaB Promotes Lung Metastasis of Cervical Cancer Cells via Upregulation of CXCR4 Expression.
    Mol Cells. 2017 Jul 6. doi: 10.14348/molcells.2017.2309.
    Abstract    

    Abstract available

  36. TANIOKA M, Yamaguchi S, Shimada M, Nagao S, et al
    Cisplatin with dose-dense paclitaxel before and after radical hysterectomy for locally advanced cervical cancer: a prospective multicenter phase II trial with a dose-finding study.
    Med Oncol. 2017;34:134.
    Abstract    

    Abstract available

  37. OHGURI T, Harima Y, Imada H, Sakurai H, et al
    Relationships between thermal dose parameters and the efficacy of definitive chemoradiotherapy plus regional hyperthermia in the treatment of locally advanced cervical cancer: Data from a multicenter randomized clinical trial.
    Int J Hyperthermia. 2017 Jul 5:1-27. doi: 10.1080/02656736.2017.1352105.
    Abstract    

    Abstract available

  38. CHONG GO, Lee WK, Jeong SY, Park SH, et al
    Prognostic value of intratumoral metabolic heterogeneity on F-18 fluorodeoxyglucose positron emission tomography/computed tomography in locally advanced cervical cancer patients treated with concurrent chemoradiotherapy.
    Oncotarget. 2017 Jun 28. doi: 10.18632/oncotarget.18769.
    Abstract    

    Abstract available

  39. KITAGAWA R, Nakanishi T, Fukaya T, Watanabe Y, et al
    [II. Current Topics and Perspective of Chemotherapy for Uterine Cervical Cancer].
    Gan To Kagaku Ryoho. 2017;44:126-130.
    Abstract    



  40. CHENG MJ, Cao YG
    TMPYP4 exerted antitumor effects in human cervical cancer cells through activation of p38 mitogen-activated protein kinase.
    Biol Res. 2017;50:24.
    Abstract    

    Abstract available

  41. YANG W, Hong L, Xu X, Wang Q, et al
    LncRNA GAS5 suppresses the tumorigenesis of cervical cancer by downregulating miR-196a and miR-205.
    Tumour Biol. 2017;39:1010428317711315.
    Abstract    

    Abstract available

  42. CHENG T, Wei R, Jiang G, Zhou Y, et al
    XPNPEP2 is overexpressed in cervical cancer and promotes cervical cancer metastasis.
    Tumour Biol. 2017;39:1010428317717122.
    Abstract    

    Abstract available

  43. YAM PWA, Lam PL, Chan TK, Chau KW, et al
    A Cross Sectional Study on Knowledge, Attitude and Practice related to Human Papillomavirus Vaccination for Cervical Cancer Prevention between Medical and Non-Medical Students in Hong Kong
    Asian Pac J Cancer Prev. 2017;18:1689-1695.
    Abstract    

    Abstract available

  44. CHENG J, Lu X, Wang J, Zhang H, et al
    Interactome analysis of gene expression profiles of cervical cancer reveals dysregulated mitotic gene clusters.
    Am J Transl Res. 2017;9:3048-3059.
    Abstract    

    Abstract available

  45. XU Z, Bian H, Zhang F, Mi R, et al
    URI promotes the migration and invasion of human cervical cancer cells potentially via upregulation of vimentin expression.
    Am J Transl Res. 2017;9:3037-3047.
    Abstract    

    Abstract available

  46. QIN Y, Ekmekcioglu S, Forget MA, Szekvolgyi L, et al
    Cervical Cancer Neoantigen Landscape and Immune Activity is Associated with Human Papillomavirus Master Regulators.
    Front Immunol. 2017;8:689.
    Abstract    

    Abstract available

  47. ZHANG MZ, Pang ZJ
    [F10 expressions in cervical cancer tissues].
    Nan Fang Yi Ke Da Xue Xue Bao. 2017;37:792-796.
    Abstract    

    Abstract available

  48. ZHANG W, Zhou J, Zhu X, Yuan H, et al
    MiR-126 reverses drug resistance to TRAIL through inhibiting the expression of c-FLIP in cervical cancer.
    Gene. 2017 Jun 29. pii: S0378-1119(17)30504-8. doi: 10.1016/j.gene.2017.
    Abstract    

    Abstract available

  49. RAJIAH K, Maharajan MK, Fang Num KS, How Koh RC, et al
    Knowledge about Human Papillomavirus and Cervical Cancer: Predictors of HPV Vaccination among Dental Students
    Asian Pac J Cancer Prev. 2017;18:1573-1579.
    Abstract    

    Abstract available

  50. AHMED HG, Bensumaidea SH, Alshammari FD, Alenazi FSH, et al
    Prevalence of Human Papillomavirus subtypes 16 and 18 among Yemeni Patients with Cervical Cancer
    Asian Pac J Cancer Prev. 2017;18:1543-1548.
    Abstract    

    Abstract available

  51. PARSA P, Sharifi F, Shobeiri F, Karami M, et al
    Effects of Group Counseling Based on Health Belief Model on Cervical Cancer Screening Beliefs and Performance of Rural Women in Kaboudrahang, Iran
    Asian Pac J Cancer Prev. 2017;18:1525-1530.
    Abstract    

    Abstract available

  52. GUPTA R, Gupta S, Mehrotra R, Sodhani P, et al
    Cervical Cancer Screening in Resource-Constrained Countries: Current Status and Future Directions
    Asian Pac J Cancer Prev. 2017;18:1461-1467.
    Abstract    

    Abstract available

  53. PAPADIA A, Gasparri ML, Genoud S, Bernd K, et al
    The combination of preoperative PET/CT and sentinel lymph node biopsy in the surgical management of early-stage cervical cancer.
    J Cancer Res Clin Oncol. 2017 Jul 1. doi: 10.1007/s00432-017-2467.
    Abstract    

    Abstract available

  54. TIRAKI Z, Yilmaz M
    Cervical Cancer Knowledge, Self-Efficacy, and Health Literacy Levels of Married Women.
    J Cancer Educ. 2017 Jul 1. doi: 10.1007/s13187-017-1242.
    Abstract    

    Abstract available

  55. UEDA T, Tsubamoto H, Inoue K, Sakata K, et al
    Itraconazole Modulates Hedgehog, WNT/beta-catenin, as well as Akt Signalling, and Inhibits Proliferation of Cervical Cancer Cells.
    Anticancer Res. 2017;37:3521-3526.
    Abstract    

    Abstract available

  56. ENKHTAIVAN G, Kim DH, Pandurangan M
    Cytotoxic effect of TDZ on human cervical cancer cells.
    J Photochem Photobiol B. 2017;173:493-498.
    Abstract    

    Abstract available

  57. PATEL-LIPPMANN K, Robbins JB, Barroilhet L, Anderson B, et al
    MR Imaging of Cervical Cancer.
    Magn Reson Imaging Clin N Am. 2017;25:635-649.
    Abstract    

    Abstract available

  58. YASRI S, Wiwanitkit V
    Zika virus infection and cervical cytology specimen.
    Am J Reprod Immunol. 2017 Mar 30. doi: 10.1111/aji.12681.
    Abstract    



  59. MENGA A, Palmieri EM, Cianciulli A, Infantino V, et al
    SLC25A26 overexpression impairs cell function via mtDNA hypermethylation and rewiring of methyl metabolism.
    FEBS J. 2017;284:967-984.
    Abstract    

    Abstract available

  60. YOO SM, Latifkar A, Cerione RA, Antonyak MA, et al
    Cool-associated Tyrosine-phosphorylated Protein 1 Is Required for the Anchorage-independent Growth of Cervical Carcinoma Cells by Binding Paxillin and Promoting AKT Activation.
    J Biol Chem. 2017;292:3947-3957.
    Abstract    

    Abstract available

  61. BHATTA MP, Johnson DC, Lama M, Aryal S, et al
    High-risk human papillomavirus infection and abnormal cervical cytology among Nepali and Bhutanese refugee women living in eastern Nepal.
    BMC Infect Dis. 2017;17:73.
    Abstract    

    Abstract available

  62. BINESH F, Karimi-Zarchi M, Vahidfar MR, Hadgiabadi ZK, et al
    Primary histiocytic sarcoma of the uterine cervix: an extremely rare entity.
    Rom J Intern Med. 2017;55:53-56.
    Abstract    

    Abstract available

  63. ZHANG Q, Zhao M, Cao D, Wei X, et al
    Assessment of the Effectiveness of HPV16/18 Infection Referred for Colposcopy in Cervical Cancer Screening in Northwest of China.
    J Med Virol. 2017 Jul 15. doi: 10.1002/jmv.24902.
    Abstract    

    Abstract available

  64. SHANKAR S, Prasad D, Sanawar R, Das AV, et al
    TALEN based HPV-E7 editing triggers necrotic cell death in cervical cancer cells.
    Sci Rep. 2017;7:5500.
    Abstract    

    Abstract available

  65. RAJI GR, Sruthi TV, Edatt L, Haritha K, et al
    Horizontal transfer of miR-106a/b from cisplatin resistant hepatocarcinoma cells can alter the sensitivity of cervical cancer cells to cisplatin.
    Cell Signal. 2017 Jul 11. pii: S0898-6568(17)30183.
    Abstract    

    Abstract available

  66. ZHANG Y, Shi T, Yin S, Ma S, et al
    An improved nerve-sparing radical hysterectomy technique for cervical cancer using the paravesico-vaginal space as a new surgical landmark.
    Oncotarget. 2017 Jul 5. doi: 10.18632/oncotarget.19011.
    Abstract    

    Abstract available

  67. SOARES S, Nogueira A, Coelho A, Assis J, et al
    Relationship between clinical toxicities and ERCC1 rs3212986 and XRCC3 rs861539 polymorphisms in cervical cancer patients.
    Int J Biol Markers. 2017 Jul 8:0. doi: 10.5301/ijbm.5000279.
    Abstract    

    Abstract available

  68. CAMPOS NG, Tsu V, Jeronimo J, Mvundura M, et al
    Evidence-based policy choices for efficient and equitable cervical cancer screening programs in low-resource settings.
    Cancer Med. 2017 Jul 14. doi: 10.1002/cam4.1123.
    Abstract    

    Abstract available

  69. ADSUL P, Manjunath N, Srinivas V, Arun A, et al
    Implementing community-based cervical cancer screening programs using visual inspection with acetic acid in India: A systematic review.
    Cancer Epidemiol. 2017;49:161-174.
    Abstract    

    Abstract available

  70. BUDUKH A, Palayekar V, Maheshwari A, Deodhar K, et al
    Menstrual pad, a cervical cancer screening tool, a population-based study in rural India.
    Eur J Cancer Prev. 2017 Jul 12. doi: 10.1097/CEJ.0000000000000387.
    Abstract    

    Abstract available

  71. WU L, Han L, Zhou C, Wei W, et al
    TGF-beta1-induced CK17 enhances cancer stem cell-like properties rather than EMT in promoting cervical cancer metastasis via the ERK1/2-MZF1 signaling pathway.
    FEBS J. 2017 Jul 13. doi: 10.1111/febs.14162.
    Abstract    

    Abstract available

  72. KIM HW, Park S, Kim Y
    Effect of community-based education to Korean mothers in relation to the prevention of cervical cancer in their daughters: A non-randomized trial.
    Jpn J Nurs Sci. 2017 Jul 13. doi: 10.1111/jjns.12179.
    Abstract    

    Abstract available

  73. LUQUE JS, Tarasenko YN, Li H, Davila CB, et al
    Utilization of Cervical Cancer Screening Among Hispanic Immigrant Women in Coastal South Carolina.
    J Racial Ethn Health Disparities. 2017 Jul 12. doi: 10.1007/s40615-017-0404.
    Abstract    

    Abstract available

  74. APAS PEREZ DE NUCCI A, Minig L, Perrotta M
    Patterns of cervical cancer care in Argentina: Applying ASCO recommendations adjusted by local resources.
    Gynecol Oncol Rep. 2017;21:61-66.
    Abstract    

    Abstract available

  75. MANGLA A, Agarwal N, Saei Hamedani F, Liu J, et al
    Metastasis of cervical cancer to breast: A case report and review of literature.
    Gynecol Oncol Rep. 2017;21:48-52.
    Abstract    

    Abstract available

  76. FUJII S, Iwata N, Inoue C, Mukuda N, et al
    Volume Measurement by Diffusion-Weighted Imaging in Cervical Cancer.
    Yonago Acta Med. 2017;60:113-118.
    Abstract    

    Abstract available

  77. YUANYUE L, Baloch Z, Yasmeen N, Tao Y, et al
    The distribution of human papillomavirus genotypes in cervical cancer and intraepithelial neoplasia lesions among Chinese women in Yunnan Province.
    J Infect Public Health. 2017 Jul 8. pii: S1876-0341(17)30173.
    Abstract    

    Abstract available

  78. MILLER TA, Flowers L
    Navigating the cervical cancer screening guidelines for women aged older than 65 years.
    Menopause. 2017 Jul 10. doi: 10.1097/GME.0000000000000913.
    Abstract    

    Abstract available

  79. NAIMER MS, Kwong JC, Bhatia D, Moineddin R, et al
    The Effect of Changes in Cervical Cancer Screening Guidelines on Chlamydia Testing.
    Ann Fam Med. 2017;15:329-334.
    Abstract    

    Abstract available

  80. LAZNIAK S, Roszak A, Balcerek A, Warenczak-Florczk Z, et al
    Role of rs13117307 single nuclear polymorphism in the risk of uterine cervical cancer from Polish population and its impact on exocyst complex component 1 expression.
    Gene. 2017 Jul 7. pii: S0378-1119(17)30523-1. doi: 10.1016/j.gene.2017.
    Abstract    

    Abstract available

  81. NESSELER JP, Charra-Brunaud C, Salleron J, Py JF, et al
    Effect of bladder distension on doses to organs at risk in Pulsed-Dose-Rate 3D image-guided adaptive brachytherapy for locally advanced cervical cancer.
    Brachytherapy. 2017 Jul 7. pii: S1538-4721(17)30368.
    Abstract    

    Abstract available

  82. IMAI K, Fukuda T, Wada T, Kawanishi M, et al
    UCP2 expression may represent a predictive marker of neoadjuvant chemotherapy effectiveness for locally advanced uterine cervical cancer.
    Oncol Lett. 2017;14:951-957.
    Abstract    

    Abstract available

  83. SONG R, Cong L, Ni G, Chen M, et al
    MicroRNA-195 inhibits the behavior of cervical cancer tumors by directly targeting HDGF.
    Oncol Lett. 2017;14:767-775.
    Abstract    

    Abstract available

  84. LEE SY, Lee NR, Cho DH, Kim JS, et al
    Treatment outcome analysis of chemotherapy combined with modulated electro-hyperthermia compared with chemotherapy alone for recurrent cervical cancer, following irradiation.
    Oncol Lett. 2017;14:73-78.
    Abstract    

    Abstract available

  85. PAREKH NK, Donohue JM, Men A, Corbelli J, et al
    Rethinking How to Measure the Appropriateness of Cervical Cancer Screening.
    Ann Intern Med. 2017 Jul 11. doi: 10.7326/L17-0140.
    Abstract    



  86. VAN ZUMMEREN M, Kremer WW, Van Aardt MC, Breytenbach E, et al
    Selection of women at risk for cervical cancer in an HIV-infected SOUTH AFRICAN population.
    AIDS. 2017 Jul 7. doi: 10.1097/QAD.0000000000001583.
    Abstract    

    Abstract available

  87. IZMAJLOWICZ B, Rusiecka M, Sztuder A, Stepien M, et al
    Tolerance of combined radiochemotherapy in cervical cancer patients.
    Adv Clin Exp Med. 2017 Jun 27. doi: 10.17219/acem/62454.
    Abstract    

    Abstract available

  88. LIN Y, Zhou J, Dai L, Cheng Y, et al
    Vaginectomy and vaginoplasty for isolated vaginal recurrence 8 years after cervical cancer radical hysterectomy: A case report and literature review.
    J Obstet Gynaecol Res. 2017 Jul 10. doi: 10.1111/jog.13375.
    Abstract    

    Abstract available

  89. ZHANG XG, Liu ZY, Liu JW, Zeng YL, et al
    Antitumor activity of a Rhodococcus sp. Lut0910 isolated from polluted soil.
    Tumour Biol. 2017;39:1010428317711661.
    Abstract    

    Abstract available

  90. SHU R, He J, Wu C, Gao J, et al
    The association between RARbeta and FHIT promoter methylation and the carcinogenesis of patients with cervical carcinoma: A meta-analysis.
    Tumour Biol. 2017;39:1010428317709126.
    Abstract    

    Abstract available

  91. SU Y, Zhang M, Zhang W, Shi H, et al
    Application research on nerve sparing radical hysterectomy for rectal function.
    Pak J Pharm Sci. 2017;30.
    Abstract    

    Abstract available

  92. KWEON SS, Kim MG, Kang MR, Shin MH, et al
    Difference of stage at cancer diagnosis by socioeconomic status for four target cancers of the National Cancer Screening Program in Korea: Results from the Gwangju and Jeonnam cancer registries.
    J Epidemiol. 2017;27:299-304.
    Abstract    

    Abstract available

  93. DIXON EP, King LM, Nelson R, Simkins SG, et al
    Characterization and clinical validation of MCM2 and TOP2A monoclonal antibodies in the BD ProEx C assay: An immunoassay which detects aberrant S-phase induction in cervical tissue.
    J Immunol Methods. 2017;442:35-41.
    Abstract    

    Abstract available

  94. WATHION N
    HPV vaccines are safe to use.
    Tidsskr Nor Laegeforen. 2017;137:13-14.
    Abstract    



  95. LEE KN, Chang KH, Cho SS, Park SH, et al
    Attitudes Regarding HPV Vaccinations of Children among Mothers with Adolescent Daughters in Korea.
    J Korean Med Sci. 2017;32:130-134.
    Abstract    

    Abstract available

  96. LEE M, Choi CH, Chun YK, Kim YH, et al
    Surgical manual of the Korean Gynecologic Oncology Group: classification of hysterectomy and lymphadenectomy.
    J Gynecol Oncol. 2017;28:e5.
    Abstract    

    Abstract available

  97. PEKER N, Gundogan S, Sendag F
    Laparoscopic Management of Huge Cervical Myoma.
    J Minim Invasive Gynecol. 2017;24:345-346.
    Abstract    

    Abstract available

  98. WOO S, Suh CH, Kim SY, Cho JY, et al
    Magnetic resonance imaging for detection of parametrial invasion in cervical cancer: An updated systematic review and meta-analysis of the literature between 2012 and 2016.
    Eur Radiol. 2017 Jul 19. doi: 10.1007/s00330-017-4958.
    Abstract    

    Abstract available

  99. HAQUE N, Uddin AFMK, Dey BR, Islam F, et al
    Challenges to cervical cancer treatment in Bangladesh: The development of a women's cancer ward at Dhaka Medical College Hospital.
    Gynecol Oncol Rep. 2017;21:67-72.
    Abstract    

    Abstract available

  100. ANDRES I, Gutierrez-Perez M, Rodriguez-Vela MP, Berenguer R, et al
    The usefulness of fleet rectal enemas on high-dose-rate intracavitary cervical cancer brachytherapy. A prospective trial.
    J Contemp Brachytherapy. 2017;9:224-229.
    Abstract    

    Abstract available

  101. ZIMMERMANN MR, Vodicka E, Babigumira JB, Okech T, et al
    Cost-effectiveness of cervical cancer screening and preventative cryotherapy at an HIV treatment clinic in Kenya.
    Cost Eff Resour Alloc. 2017;15:13.
    Abstract    

    Abstract available

  102. BAUSSANO I, Tshering S, Choden T, Lazzarato F, et al
    Cervical cancer screening in rural Bhutan with the careHPV test on self-collected samples: an ongoing cross-sectional, population-based study (REACH-Bhutan).
    BMJ Open. 2017;7:e016309.
    Abstract    

    Abstract available

  103. MARCHETTI C, Felice F, Pinto AD, Romito A, et al
    Survival Nomograms After Curative Neoadjuvant Chemotherapy and Radical Surgery for Stage IB2-IIIB Cervical Cancer.
    Cancer Res Treat. 2017 Jul 19. doi: 10.4143/crt.2017.
    Abstract    

    Abstract available

  104. CHEN RJ, Shun CT, Yen ML, Chou CH, et al
    Methyltransferase G9a promotes cervical cancer angiogenesis and decreases patient survival.
    Oncotarget. 2017 Jul 7. doi: 10.18632/oncotarget.19060.
    Abstract    

    Abstract available

  105. VIANA LDS, Balmant NV, de Paula Silva N, Santos MO, et al
    Incidence Trends of Cervical Cancer in Adolescents and Young Adults: Brazilian Population Based Data.
    J Adolesc Young Adult Oncol. 2017 Jul 19. doi: 10.1089/jayao.2017.0048.
    Abstract    

    Abstract available

  106. STURDZA A, Hofmann S, Kranawetter M, Polterauer S, et al
    Increased genitourinary fistula rate after bevacizumab in recurrent cervical cancer patients initially treated with definitive radiochemotherapy and image-guided adaptive brachytherapy.
    Strahlenther Onkol. 2017 Jul 18. doi: 10.1007/s00066-017-1178.
    Abstract    

    Abstract available

  107. LEE EH, Ji KY, Kim EM, Kim SM, et al
    Blockade of Axl signaling ameliorates HPV16E6-mediated tumorigenecity of cervical cancer.
    Sci Rep. 2017;7:5759.
    Abstract    

    Abstract available

  108. LI LR, Lin MG, Liang J, Hu QY, et al
    Effects of Intrinsic and Extrinsic Factors on the Level of Hope and Psychological Health Status of Patients with Cervical Cancer During Radiotherapy.
    Med Sci Monit. 2017;23:3508-3517.
    Abstract    

    Abstract available

  109. BAUSSANO I, Diaz M, Tully S, Munoz N, et al
    Effect of age-difference between heterosexual partners on risk of cervical cancer and human papillomavirus infection.
    Papillomavirus Res. 2017;3:98-104.
    Abstract    

    Abstract available

  110. MO X, Gai Tobe R, Wang L, Liu X, et al
    Cost-effectiveness analysis of different types of human papillomavirus vaccination combined with a cervical cancer screening program in mainland China.
    BMC Infect Dis. 2017;17:502.
    Abstract    



  111. YANG P, Chen N, Yang D, Crane J, et al
    Cervical cancer cell-derived angiopoietins promote tumor progression.
    Tumour Biol. 2017;39:1010428317711658.
    Abstract    

    Abstract available

  112. MIER-GIRALDO H, Diaz-Barrera LE, Delgado-Murcia LG, Valero-Valdivieso MF, et al
    Cytotoxic and Immunomodulatory Potential Activity of Physalis peruviana Fruit Extracts on Cervical Cancer (HeLa) and Fibroblast (L929) Cells.
    J Evid Based Complementary Altern Med. 2017 Jan 1:2156587217718751.
    Abstract    

    Abstract available

  113. HOU H, Er P, Cheng J, Chen X, et al
    High expression of FUNDC1 predicts poor prognostic outcomes and is a promising target to improve chemoradiotherapy effects in patients with cervical cancer.
    Cancer Med. 2017 Jul 18. doi: 10.1002/cam4.1112.
    Abstract    

    Abstract available

  114. HALEC G, Dondog B, Pawlita M, Schmitt M, et al
    Concordance of HPV load and HPV mRNA for 16 carcinogenic/possibly carcinogenic HPV types in paired smear/tissue cervical cancer specimens.
    Arch Virol. 2017 Jul 17. doi: 10.1007/s00705-017-3452.
    Abstract    

    Abstract available

  115. HOWITT BE, Herfs M, Tomoka T, Kamiza S, et al
    Comprehensive Human Papillomavirus Genotyping in Cervical Squamous Cell Carcinomas and Its Relevance to Cervical Cancer Prevention in Malawian Women.
    J Glob Oncol. 2016;3:227-234.
    Abstract    

    Abstract available

  116. GYAWALI B, Iddawela M
    Bevacizumab in Advanced Cervical Cancer: Issues and Challenges for Low- and Middle-Income Countries.
    J Glob Oncol. 2016;3:93-97.
    Abstract    

    Abstract available

  117. CHAMBUSO RS, Shadrack S, Lidenge SJ, Mwakibete N, et al
    Influence of HIV/AIDS on Cervical Cancer: A Retrospective Study From Tanzania.
    J Glob Oncol. 2016;3:72-78.
    Abstract    

    Abstract available

  118. LIANG B, Li Y, Wang T
    A three miRNAs signature predicts survival in cervical cancer using bioinformatics analysis.
    Sci Rep. 2017;7:5624.
    Abstract    

    Abstract available

  119. SHIN S, Im HJ, Kwon YJ, Ye DJ, et al
    Human steroid sulfatase induces Wnt/beta-catenin signaling and epithelial-mesenchymal transition by upregulating Twist1 and HIF-1alpha in human prostate and cervical cancer cells.
    Oncotarget. 2017 Jun 27. doi: 10.18632/oncotarget.18645.
    Abstract    

    Abstract available

  120. ORFANELLI T, Chung S, Kohut A, Gibbon D, et al
    Olgilvie's Syndrome after Robotic Assisted Radical Hysterectomy for Cervical Cancer.
    J Minim Invasive Gynecol. 2017 Jul 12. pii: S1553-4650(17)30389.
    Abstract    

    Abstract available

  121. XING Y, Wang C, Wu J
    Expression of geminin, p16, and Ki67 in cervical intraepithelial neoplasm and normal tissues.
    Medicine (Baltimore). 2017;96:e7302.
    Abstract    

    Abstract available

  122. YANG-CHUN F, Zhen-Zhen C, Yan-Chun H, Xiu-Min M, et al
    Association between PD-L1 and HPV status and the prognostic value for HPV treatment in premalignant cervical lesion patients.
    Medicine (Baltimore). 2017;96:e7270.
    Abstract    

    Abstract available

  123. NASEEM A, Bhat ZI, Kalaiarasan P, Kumar B, et al
    Genetic and epigenetic alterations affecting PARK-2 expression in cervical neoplasm among North Indian patients.
    Tumour Biol. 2017;39:1010428317703635.
    Abstract    

    Abstract available

  124. HARDEN ME, Munger K
    Perturbation of DROSHA and DICER expression by human papillomavirus 16 oncoproteins.
    Virology. 2017;507:192-198.
    Abstract    

    Abstract available

  125. PIGUET V
    Heat-Induced Editing of HPV Genes to Clear Mucocutaneous Warts?
    J Invest Dermatol. 2017;137:796-797.
    Abstract    

    Abstract available

  126. OLAKU OO, Taylor EA
    Cancer in the Medically Underserved Population.
    Prim Care. 2017;44:87-97.
    Abstract    

    Abstract available

  127. FERNANDEZ LM, Becker JA
    Women's Select Health Issues in Underserved Populations.
    Prim Care. 2017;44:47-55.
    Abstract    

    Abstract available

  128. JORGENSEN KR, Hoyer S, Sorensen MM, Jensen JB, et al
    Human papillomavirus types 44, 52, 66 and 67 detected in a woman with squamous cell carcinoma of the urinary bladder.
    Scand J Urol. 2017;51:85-86.
    Abstract    

    Abstract available

  129. VAHEDPOOR Z, Jamilian M, Bahmani F, Aghadavod E, et al
    Effects of Long-Term Vitamin D Supplementation on Regression and Metabolic Status of Cervical Intraepithelial Neoplasia: a Randomized, Double-Blind, Placebo-Controlled Trial.
    Horm Cancer. 2017;8:58-67.
    Abstract    

    Abstract available

  130. CHEN Z, Shi Y, Wang S, Lu Q, et al
    Meta-analysis showing that early response to neoadjuvant chemotherapy predicts better survival among cervical cancer patients.
    Oncotarget. 2017 Jul 21. doi: 10.18632/oncotarget.19425.
    Abstract    

    Abstract available

  131. BAI Y, Liu Q, Chen X, Gao Y, et al
    Protection Motivation Theory in Predicting Intention to Receive Cervical Cancer Screening in Rural Chinese Women.
    Psychooncology. 2017 Jul 27. doi: 10.1002/pon.4510.
    Abstract    

    Abstract available

  132. KRAKOW M, Yale RN, Perez Torres D, Christy K, et al
    Death Narratives and Cervical Cancer: Impact of Character Death on Narrative Processing and HPV Vaccination.
    Health Psychol. 2017 Jul 27. doi: 10.1037/hea0000498.
    Abstract    

    Abstract available

  133. PHUTHONG S, Settheetham-Ishida W, Natphopsuk S, Settheetham D, et al
    Haplotype Analysis of MDR1 and Risk for Cervical Cancer in Northeastern Thailand
    Asian Pac J Cancer Prev. 2017;18:1815-1819.
    Abstract    

    Abstract available

  134. SHEN WJ, Fu S, Li N, Li LL, et al
    Decreased Mean Platelet Volume is Associated with Cervical Cancer Development
    Asian Pac J Cancer Prev. 2017;18:1769-1772.
    Abstract    

    Abstract available

  135. ISLAM RM, Billah B, Hossain MN, Oldroyd J, et al
    Barriers to Cervical Cancer and Breast Cancer Screening Uptake in Low-Income and Middle-Income Countries: A Systematic Review
    Asian Pac J Cancer Prev. 2017;18:1751-1763.
    Abstract    

    Abstract available

  136. BARCELOS MRB, Lima RCD, Tomasi E, Nunes BP, et al
    Quality of cervical cancer screening in Brazil: external assessment of the PMAQ.
    Rev Saude Publica. 2017;51:67.
    Abstract    

    Abstract available


  137. Improved Survival with Bevacizumab in Advanced Cervical Cancer.
    N Engl J Med. 2017 Jul 26. doi: 10.1056/NEJMx170002.
    Abstract    



  138. JI F, Wuerkenbieke D, He Y, Ding Y, et al
    Long Noncoding RNA HOTAIR: An Oncogene in Human Cervical Cancer Interacting with MicroRNA-17-5p.
    Oncol Res. 2017 Jul 26. doi: 10.3727/096504017X15002869385155.
    Abstract    

    Abstract available

  139. SHEN MX, Ding JB
    Expression levels and roles of EMC-6, Beclin1, and Rab5a in the cervical cancer.
    Eur Rev Med Pharmacol Sci. 2017;21:3038-3046.
    Abstract    

    Abstract available

  140. LUAN S, An Z, Bi S, Chen L, et al
    Interleukin 6 receptor (IL-6R) was an independent prognostic factor in cervical cancer.
    Histol Histopathol. 2017 Jul 25:11920. doi: 10.14670.
    Abstract    

    Abstract available

  141. GELE AA, Qureshi SA, Kour P, Kumar B, et al
    Barriers and facilitators to cervical cancer screening among Pakistani and Somali immigrant women in Oslo: a qualitative study.
    Int J Womens Health. 2017;9:487-496.
    Abstract    

    Abstract available

  142. ZHANG J, Yao T, Lin Z, Gao Y, et al
    Aberrant Methylation of MEG3 Functions as a Potential Plasma-Based Biomarker for Cervical Cancer.
    Sci Rep. 2017;7:6271.
    Abstract    

    Abstract available

  143. WANG SG, Mu N, Sun HY
    Effect of Interventional Therapy on the Expression of Survivin mRNA in Cervical Cancer.
    Anticancer Res. 2017;37:4707-4710.
    Abstract    

    Abstract available

  144. THOMAS-PURCELL KB, Tarver WL, Richards C, Primus-Joseph M, et al
    Gatekeepers' perceptions of the quality and availability of services for breast and cervical cancer patients in the English-speaking Windward Islands: an exploratory investigation.
    Cancer Causes Control. 2017 Jul 21. doi: 10.1007/s10552-017-0925.
    Abstract    

    Abstract available

  145. SUN LY, Tao JZ, Yan B, Lin JS, et al
    Inhibitory effects of FKBP14 on human cervical cancer cells.
    Mol Med Rep. 2017 Jul 21. doi: 10.3892/mmr.2017.7043.
    Abstract    

    Abstract available

  146. ZHOU W, Huang C, Zou X, Lu Y, et al
    Exhaled breath online measurement for cervical cancer patients and healthy subjects by proton transfer reaction mass spectrometry.
    Anal Bioanal Chem. 2017 Jul 20. doi: 10.1007/s00216-017-0498.
    Abstract    

    Abstract available

  147. SCHORGE JO, Russo AL, Greene MF, Woythaler MA, et al
    Case 21-2017. A 28-Year-Old Pregnant Woman with Endocervical Carcinoma.
    N Engl J Med. 2017;377:174-182.
    Abstract    



  148. CONG Q, Wang Q, Gao SJ, Zhang HW, et al
    [Detection trend of vaginal intraepithelial neoplasia diagnosed by colposcopy guided biopsy from 2013 to 2015].
    Zhonghua Fu Chan Ke Za Zhi. 2017;52:239-243.
    Abstract    

    Abstract available

  149. WANG P, Liu S, Cheng B, Wu XZ, et al
    [Promoting effect of cyclin D1 overexpression on proliferation and epithelial mesenchymal transition of cervical squamous cell carcinoma SiHa cells].
    Zhonghua Bing Li Xue Za Zhi. 2017;46:187-192.
    Abstract    

    Abstract available

  150. SCHNEIDER V
    Criticism of the Pap Smear as a Diagnostic Tool in Cervical Cancer Screening.
    Acta Cytol. 2017;61.
    Abstract    

    Abstract available

  151. MILLS AM, Paquette C, Terzic T, Castle PE, et al
    CK7 Immunohistochemistry as a Predictor of CIN1 Progression: A Retrospective Study of Patients From the Quadrivalent HPV Vaccine Trials.
    Am J Surg Pathol. 2017;41:143-152.
    Abstract    

    Abstract available

  152. TALIA KL, McCluggage WG
    Seborrheic Keratosis-like Lesions of the Cervix and Vagina: Report of a New Entity Possibly Related to Low-risk Human Papillomavirus Infection.
    Am J Surg Pathol. 2017;41:517-524.
    Abstract    

    Abstract available

  153. LAJER CB, Garnaes E, Friis-Hansen L, Norrild B, et al
    The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer.
    Br J Cancer. 2017 Jul 13. doi: 10.1038/bjc.2017.
    Abstract    

    Abstract available

  154. KYO S, Kato T, Nakayama K
    Current concepts and practical techniques of nerve-sparing laparoscopic radical hysterectomy.
    Eur J Obstet Gynecol Reprod Biol. 2016;207:80-88.
    Abstract    

    Abstract available

  155. NI T, Sun X, Shan B, Wang J, et al
    Detection of circulating tumour cells may add value in endometrial cancer management.
    Eur J Obstet Gynecol Reprod Biol. 2016;207:1-4.
    Abstract    

    Abstract available

  156. DE AZEVEDO CRAS, Thuler LCS, de Mello MJG, de Oliveira Lima JT, et al
    Phase II trial of neoadjuvant chemotherapy followed by chemoradiation in locally advanced cervical cancer.
    Gynecol Oncol. 2017 Jul 11. pii: S0090-8258(17)31023.
    Abstract    

    Abstract available

  157. HARPER DM, DeMars LR
    HPV vaccines - A review of the first decade.
    Gynecol Oncol. 2017 Apr 22. pii: S0090-8258(17)30774.
    Abstract    

    Abstract available

  158. LI H, Sheng Y, Zhang Y, Gao N, et al
    MicroRNA-138 is a potential biomarker and tumor suppressor in human cervical carcinoma by reversely correlated with TCF3 gene.
    Gynecol Oncol. 2017 Apr 3. pii: S0090-8258(17)30062.
    Abstract    

    Abstract available

  159. KANAO H, Aoki Y, Hisa T, Takeshima N, et al
    Total laparoscopic pelvic exenteration for a laterally recurrent cervical carcinoma with a vesicovaginal fistula that developed after concurrent chemoradiotherapy.
    Gynecol Oncol. 2017 May 30. pii: S0090-8258(17)30886.
    Abstract    

    Abstract available

  160. CARLANDER C, Wagner P, Svedhem V, Elfgren K, et al
    Impact of immunosuppression and region of birth on risk of cervical intraepithelial neoplasia among migrants living with HIV in Sweden.
    Int J Cancer. 2016 May 13. doi: 10.1002/ijc.30188.
    Abstract    

    Abstract available

  161. MASSAD LS, Hessol NA, Darragh TM, Minkoff H, et al
    Cervical cancer incidence after up to 20 years of observation among women with HIV.
    Int J Cancer. 2017 Jul 3. doi: 10.1002/ijc.30866.
    Abstract    

    Abstract available

  162. VACCARELLA S, Laversanne M, Ferlay J, Bray F, et al
    Cervical cancer in Africa, Latin America and the Caribbean, and Asia: Regional inequalities and changing trends.
    Int J Cancer. 2017 Jul 22. doi: 10.1002/ijc.30901.
    Abstract    

    Abstract available

  163. OGILVIE G, Nakisige C, Huh WK, Mehrotra R, et al
    Optimizing secondary prevention of cervical cancer: Recent advances and future challenges.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:15-19.
    Abstract    

    Abstract available

  164. WHITE HL, Meglioli A, Chowdhury R, Nuccio O, et al
    Integrating cervical cancer screening and preventive treatment with family planning and HIV-related services.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:41-46.
    Abstract    

    Abstract available

  165. BASU P, Meheus F, Chami Y, Hariprasad R, et al
    Management algorithms for cervical cancer screening and precancer treatment for resource-limited settings.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:26-32.
    Abstract    

    Abstract available

  166. TSU VD
    Cervical cancer prevention for all women: Why now?
    Int J Gynaecol Obstet. 2017;138 Suppl 1:1-3.
    Abstract    



  167. CAMPOS NG, Sharma M, Clark A, Lee K, et al
    The health and economic impact of scaling cervical cancer prevention in 50 low- and lower-middle-income countries.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:47-56.
    Abstract    

    Abstract available

  168. WITTET S, Aylward J, Cowal S, Drope J, et al
    Advocacy, communication, and partnerships: Mobilizing for effective, widespread cervical cancer prevention.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:57-62.
    Abstract    

    Abstract available

  169. HOLME F, Kapambwe S, Nessa A, Basu P, et al
    Scaling up proven innovative cervical cancer screening strategies: Challenges and opportunities in implementation at the population level in low- and lower-middle-income countries.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:63-68.
    Abstract    

    Abstract available

  170. DRUMMOND JL, Were MC, Arrossi S, Wools-Kaloustian K, et al
    Cervical cancer data and data systems in limited-resource settings: Challenges and opportunities.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:33-40.
    Abstract    

    Abstract available

  171. TSU VD, Ginsburg O
    The investment case for cervical cancer elimination.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:69-73.
    Abstract    

    Abstract available

  172. ARANDA S, Berkley S, Cowal S, Dybul M, et al
    Ending cervical cancer: A call to action.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:4-6.
    Abstract    

    Abstract available

  173. LUCIDI A, Windemut S, Petrillo M, Dessole M, et al
    Self-Reported Long-Term Autonomic Function After Laparoscopic Total Mesometrial Resection for Early-Stage Cervical Cancer: A Multicentric Study.
    Int J Gynecol Cancer. 2017 Jul 13. doi: 10.1097/IGC.0000000000001045.
    Abstract    

    Abstract available

  174. CHANTALAT E, Vidal F, Motton S
    Letter to the Editor on "Management of Para-aortic Lymph Node Disease in Patients With Cervical Cancer": What is the Best Approach? Int J Gynecol Cancer. 2017 Mar; 27(3): 543549.
    Int J Gynecol Cancer. 2017 Jul 13. doi: 10.1097/IGC.0000000000001085.
    Abstract    



  175. NARTEY Y, Hill PC, Amo-Antwi K, Nyarko KM, et al
    Factors Contributing to the Low Survival Among Women With a Diagnosis of Invasive Cervical Cancer in Ghana.
    Int J Gynecol Cancer. 2017 Jul 13. doi: 10.1097/IGC.0000000000001088.
    Abstract    

    Abstract available

  176. PANG T, Li M, Zhang Y, Yong W, et al
    Y Box-Binding Protein 1 Promotes Epithelial-Mesenchymal Transition, Invasion, and Metastasis of Cervical Cancer via Enhancing the Expressions of Snail.
    Int J Gynecol Cancer. 2017 Jul 13. doi: 10.1097/IGC.0000000000001066.
    Abstract    

    Abstract available

  177. VAN GENT MDJM, Rademaker M, van der Veer JCB, van Poelgeest MIE, et al
    Long-Term Oncological Outcome After Conventional Radical Hysterectomy Versus 2 Nerve-Sparing Modalities for Early Stage Cervical Cancer.
    Int J Gynecol Cancer. 2017 Jul 12. doi: 10.1097/IGC.0000000000001067.
    Abstract    

    Abstract available

  178. MACHIDA H, Eckhardt SE, Antonio C, Blake EA, et al
    Single Marital Status and Infectious Mortality in Women With Cervical Cancer in the United States.
    Int J Gynecol Cancer. 2017 Jul 12. doi: 10.1097/IGC.0000000000001068.
    Abstract    

    Abstract available

  179. BINGHAM B, Orton A, Boothe D, Stoddard G, et al
    Brachytherapy Improves Survival in Stage III Endometrial Cancer With Cervical Involvement.
    Int J Radiat Oncol Biol Phys. 2017;97:1040-1050.
    Abstract    

    Abstract available

  180. LI N, Carmona R, Sirak I, Kasaova L, et al
    Highly Efficient Training, Refinement, and Validation of a Knowledge-based Planning Quality-Control System for Radiation Therapy Clinical Trials.
    Int J Radiat Oncol Biol Phys. 2017;97:164-172.
    Abstract    

    Abstract available

  181. JHAWAR S, Hathout L, Elshaikh MA, Beriwal S, et al
    Adjuvant Chemoradiation Therapy for Cervical Cancer and Effect of Timing and Duration on Treatment Outcome.
    Int J Radiat Oncol Biol Phys. 2017;98:1132-1141.
    Abstract    

    Abstract available

  182. KIM TH, Kim MH, Kim BJ, Park SI, et al
    Prognostic Importance of the Site of Recurrence in Patients With Metastatic Recurrent Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2017;98:1124-1131.
    Abstract    

    Abstract available

  183. SUN CY, Chu ZB, Huang J, Chen L, et al
    siRNA-mediated inhibition of endogenous brainderived neurotrophic factor gene modulates the biological behavior of HeLa cells.
    Oncol Rep. 2017;37:2751-2760.
    Abstract    

    Abstract available

  184. WU X, Zhou J, Cai D, Li M, et al
    Matrine inhibits the metastatic properties of human cervical cancer cells via downregulating the p38 signaling pathway.
    Oncol Rep. 2017 Jul 3. doi: 10.3892/or.2017.5787.
    Abstract    

    Abstract available

  185. DONG W, Sun S, Cao X, Cui Y, et al
    Exposure to TNFalpha combined with TGFbeta induces carcinogenesis in vitro via NF-kappaB/Twist axis.
    Oncol Rep. 2017;37:1873-1882.
    Abstract    

    Abstract available

  186. LI X, Wang H, Du X, Yu W, et al
    Lactobacilli inhibit cervical cancer cell migration in vitro and reduce tumor burden in vivo through upregulation of E-cadherin.
    Oncol Rep. 2017 Jul 5. doi: 10.3892/or.2017.5791.
    Abstract    

    Abstract available

  187. LI X, Zhou Q, Tao L, Yu C, et al
    MicroRNA-106a promotes cell migration and invasion by targeting tissue inhibitor of matrix metalloproteinase 2 in cervical cancer.
    Oncol Rep. 2017 Jul 18. doi: 10.3892/or.2017.5832.
    Abstract    

    Abstract available

  188. KARAGEORGOPOULOU S, Kostakis ID, Gazouli M, Markaki S, et al
    Prognostic and predictive factors in patients with metastatic or recurrent cervical cancer treated with platinum-based chemotherapy.
    BMC Cancer. 2017;17:451.
    Abstract    

    Abstract available

  189. MCKAY J, Tenet V, Franceschi S, Chabrier A, et al
    Correction: Immuno-related polymorphisms and cervical cancer risk: The IARC multicentric case-control study.
    PLoS One. 2017;12:e0181285.
    Abstract    

    Abstract available

  190. SANO H, Goto R, Hamashima C
    Does lack of resources impair access to breast and cervical cancer screening in Japan?
    PLoS One. 2017;12:e0180819.
    Abstract    

    Abstract available

  191. CABRERA-BECERRIL A, Vargas-De-Leon C, Hernandez S, Miramontes P, et al
    Modeling the dynamics of chromosomal alteration progression in cervical cancer: A computational model.
    PLoS One. 2017;12:e0180882.
    Abstract    

    Abstract available

  192. AWEKE YH, Ayanto SY, Ersado TL
    Knowledge, attitude and practice for cervical cancer prevention and control among women of childbearing age in Hossana Town, Hadiya zone, Southern Ethiopia: Community-based cross-sectional study.
    PLoS One. 2017;12:e0181415.
    Abstract    

    Abstract available

  193. SIGFRID L, Murphy G, Haldane V, Chuah FLH, et al
    Integrating cervical cancer with HIV healthcare services: A systematic review.
    PLoS One. 2017;12:e0181156.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;